01 3Boehringer Ingelheim (Canada) Ltd.
01 12187523
02 12294033
03 12346131
01 3Tipranavir
01 3Capsule
01 12015-05-04
02 12018-07-27
03 12019-10-29
Patent Expiration Date : 2018-07-27
Date Granted : 2007-01-09
Brand Name : APTIVUS
Patent Number : 2294033
Filing Date : 1998-07-27
Strength per Unit : 250 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-07-27
Date Granted : 2007-01-09
Patent Expiration Date : 2015-05-04
Date Granted : 2006-11-21
Brand Name : APTIVUS
Patent Number : 2187523
Filing Date : 1995-05-04
Strength per Unit : 250 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2015-05-04
Date Granted : 2006-11-21
Patent Expiration Date : 2019-10-29
Date Granted : 2013-01-15
Brand Name : APTIVUS
Patent Number : 2346131
Filing Date : 1999-10-29
Strength per Unit : 250 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-10-29
Date Granted : 2013-01-15
